BellaTek Bars
ZimVie US Corp, LLC · Decision date Sep 21, 2026
What did the FDA decide?
ZimVie US Corp, LLC received a substantially equivalent (SESE) determination for BellaTek Bars under 510(k) K260940, decided September 21, 2026, with the application received March 20, 2026. The device is a Class II endosseous dental implant abutment (21 CFR 872.3630, product code NHA) reviewed by the Division of Dental and ENT Devices. The submission is recorded as a Special 510(k) with a summary dated September 15, 2026, and lists K241032 (BellaTek Bars, cleared July 15, 2024) as primary predicate, with several DESS Dental Smart Solutions clearances as reference devices.
The stated indication covers attachment to dental abutments in partially or fully edentulous jaws to restore chewing function, with a minimum of two abutments, and lists compatibility with multiple DESS multi-unit abutment systems. The summary's substantial equivalence table points to indications, design matrix specifications, materials and processing as the comparison basis. SESE is a clearance, not premarket approval. The source does not identify the specific changed item or the supporting test data, and no clinical or performance results are included.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Sep 21, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260940
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ZimVie US Corp, LLC
- Product code
- NHA
- Decision code
- SESE
- Decision date
- Sep 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Abutment, Implant, Dental, Endosseous.
- Applicant
- ZimVie US Corp, LLC
- Product code
- NHA
- FDA device class
- 2
FDA decision timeline
K260940 received
Application receipt date recorded by FDA.
K260940 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NHA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Elos Accurate Hybrid BaseK261327 | Elos Medtech Pinol A/S | 510(k) clearance | Sep 30, 2026 | FDA |
Cemented Plus AbutmentK262207 | Unidental Co., Ltd. | 510(k) clearance | Sep 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ZimVie US Corp, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Palm Beach Gardens, FL
Sources and methodology
- Original FDA record: K260940
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records